Can Texting Patients Who Are Scheduled for Colonoscopy Reduce 'No-Shows'?
According to the ACS, colorectal cancer is the third most common cause of cancer in both men and women in the U.S. They also estimate that there will be nearly 101,420 cases...
Can Zapping Your Brain Really Make You Smarter?
This is a mounting problem as consumer use of tDCS and of other neurotech applications, such as personal EEG devices and brain fitness software, rapidly grows. Medical...
CANCELED: MBE CLASSES
All MBE classes have been canceled for Monday, December 2, 2019. Please contact AJ Roholt with questions at: arroholt@pennmedicine.upenn.edu.
Cancer patients are eager to use immunotherapy but sometimes chemotherapy is the far better option
By Ravi Parikh for The Washington Post: I recently met a decorated Vietnam veteran with Stage 4 bladder cancer in my clinic. He told me he was willing to do "whatever it...
Cancer patients shouldn’t be responsible for out-of-pocket costs
By Ezekiel J. Emanuel May 23, 2023 for STAT EXCERPT: In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure multiple CT and MRI studies...
Cancer Treatment Tackles a New Frontier: Chemo at Home, Even on the Go
From The Philadelphia Inquirer Chemotherapy at home is a rising trend, driven by patient convenience and the widespread fear of hospitals during the pandemic. But as much...
Candice Player
Candice Player joined Project HOME in July 2019. In her role as the Vice President of Advocacy, Public Policy and Street Outreach, Player provides mission-focused leadership...
CAR-T Costs 'Not Sustainable' for Hospitals, Researchers Say
A breakthrough therapy to treat certain advanced blood cancers, known as chimeric antigen receptor T-cell therapy, has shown promising results — even complete remissions in...